Drug all set to benefit patients

Aug 20 2007

by Douglas Young, Evening Chronicle

AROUND 5,500 pre-menopausal breast cancer patients could be offered a hormone drug that is shown to be as effective as traditional chemotherapy. According to a Cancer Research UK report published in The Lancet, the drug could help avoid potential infertility and long-term menopausal side effects of other treatments. Hormone therapy drugs which stop the ovaries from producing oestrogen is as effective as conventional chemotherapy for many pre-menopausal breast cancer patients with the added benefit of them being better tolerated by patients. This means women, whose breast cancer is hormone sensitive, may not need risk becoming permanently infertile or suffering the unpleasant side effects caused by chemotherapy. The report showed when pre-menopausal women were treated with a particular hormone therapy drug their chance of the disease recurring was no higher than having chemotherapy alone. Story continues ADVERTISEMENT The drugs, called LHRH agonists, stop the pituitary gland producing luteinising hormone, and so remove the stimulus for the ovaries to make oestrogen. But once the treatment stops the ovarian function usually returns to normal. When younger breast cancer patients have chemotherapy the treatment accelerates the menopause and can deny women the chance to have children. In addition, many women suffer from long-term unpleasant post-menopausal side effects.

Top | Back | E-mail to a friend | Printable version

Copyright and Trade Mark Notice

© 2010 owned by or licensed to ncjMedia Limited. icNewcastle™ is a trade mark of ncjMedia Limited. Please read our Terms and Conditions and Privacy Statement before using this site.

 

Jobs Newcastle, Homes in Northeast, Used Cars Northeast, Newcastle Free Classified ads Mortgages, Jobs in Newcastle Local Mole - Local Directory